Helius Therapeutics
In 2017, Paul Manning co-founded biotechnology firm, Helius Therapeutics, focused on researching, developing and commercialising medicinal cannabis. In 2018 we raise $15m in our Series A & B capital rounds and in 2020 we raised a further $20m, taking our market cap to $105m. Today, Helius is New Zealand's largest licensed medicinal cannabis company.
This person is not in any offices
Helius Therapeutics
8 followers
Helius is a New Zealand-owned biotechnology company focused on medicinal cannabis research and development. The country’s largest licensed producer and the first medicinal cannabis cultivator to be certified as New Zealand Grown through Buy NZ Made Campaign, Helius a leader in this nascent market. The company operates a state-of-the-art GMP facility in Auckland with indoor controlled growing systems, integrated extraction site, an advanced cannabinoid research laboratory and manufacturing operations. Following changes in New Zealand’s regulatory environment, Helius is poised to set the standard for effective and accessible medicinal cannabis products.